Get started
APOLLO HOSPITALS ENTER. LAPOLLO HOSPITALS ENTER. LAPOLLO HOSPITALS ENTER. L

APOLLO HOSPITALS ENTER. L

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

APOLLOHOSP trade ideas

APOLLOHOSP & PETRONETI have tried to place both the chart set ups in same screen.. Both had a decent rally followed by sideways consolidation Apollo Hospital Brokeout and moving high.. Next Petronet is in line.. Petronet is coming out of the falling trendline.. Good scripts for watch for Jan Series I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions. Please consider my views only to get a different perspective (FOR or AGAINST your views). Please don't trade FNO based on my views.
NSE:APOLLOHOSP
by Murthy_Santhosh
APOLLOHOSP for 8100? Bearish Crab Pattern is visibleCMP: 7193 On hourly TF, Bearish Crab Harmonic pattern is activated by breaking the swing high at 7150 levels. If this pattern has to mature, then, it will have to make a run towards 8100 levels (1.618% of the XA leg) As per this pattern, the ideal trade set up scenario is that, ONE SHOULD WAIT FOR THE PRZ (POTENTIAL REVERSAL ZONE) and initiate the trade in the opposite direction.. In this case, WE SHOULD WAIT FOR THE PATTERN TO MATURE AT 8100-200 LEVELS and take a SHORT trade with minimal Stoploss. For COMPULSIVE TRADERS who would like to take advantage of this possible/potential 1000 points move on the upside, the BEST Risk Reward is at around 7000-7050 levels with 100 points SL Although this up-move projection looks pre-emptive , it bodes well with my primary view of the 5th in play as explained in the post below and also the daily chart copied below with counts I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions.
NSE:APOLLOHOSPLong
by Murthy_Santhosh
Apollo hospital bullish VIEWApollo hospitalbullish VIEW is on Trendline ,Target will be in coming days Targets: Greenline T1-7300 T2: 7400 T3: 7500 Imp. Note: This analysis is provided for informational purposes only and does not constitute a direct recommendation to buy or sell stocks. Investors should conduct their own research and consult with financial advisors before making any investment decisions, as market conditions and individual circumstances may vary. Market Risk: However, it's important to acknowledge the inherent risks
NSE:APOLLOHOSPLong
by KarthiKeyan3c
1
A Healthcare Face-Off: Apollo vs. Narayana◉ Abstract India's hospital industry is growing rapidly, valued at ₹8.35 lakh cr. ($98.98 B) in 2023, with a projected CAGR of 5.8-8.0% from 2024 to 2032. Apollo Hospitals and Narayana Hrudayalaya are two leading players, with Apollo being the largest private hospital network and Narayana Hrudayalaya known for cost-effective cardiac care. Narayana Hrudayalaya appears undervalued with a P/E ratio of 33.5 and more profitable (ROCE: 27%), making it an attractive investment option. Apollo Hospitals seems overvalued with a P/E ratio of 83.4 but remains viable for strategic entry points. Both companies are poised for growth driven by increasing healthcare demands and infrastructure expansion. Read full analysis here........ ◉ Introduction The hospital industry in India is experiencing significant growth, with the market valued at approximately ₹8.35 lakh cr. ($98.98 B) in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 5.8% to 8.0% from 2024 to 2032, potentially reaching between 13.87 lakh cr. and 16.33 lakh cr. ($164.4 B - $193.6 B) by 2032, depending on various market analyses. ◉ Growth Drivers of the Indian Hospital Industry ● Increased Healthcare Expenditure: ➖ Rising public and private spending on healthcare, with government health expenditure aiming for 2.5% of GDP by 2025. ➖ Expanding middle class with higher disposable incomes and greater access to health insurance. ● Technological Advancements: ➖ Adoption of healthcare technologies such as telemedicine and robotic automation, improving service delivery. ➖ National Digital Health Blueprint promoting innovations in e-health. ● Policy Support and Foreign Investment: ➖ Favourable government policies allowing 100% FDI in healthcare, attracting significant investments. ➖ Public-private partnerships enhancing healthcare access, especially in underserved areas. ● Demand for Specialized Services: ➖ Increasing incidence of lifestyle diseases driving demand for specialized healthcare. ➖ Growth in medical tourism as India becomes a preferred destination for cost-effective treatments. These factors are collectively propelling the growth of the hospital industry in India, positioning it for a promising future. ◉ Key players in the Indian hospital sector 1. Apollo Hospitals leads the sector with a market capitalization of approximately ₹98,646 Cr, establishing itself as the largest private hospital network in India. 2. Max Healthcare closely follows, boasting a market capitalization of around ₹97,820 Cr. 3. Fortis Healthcare is another key participant in the market, with a market capitalization of ₹48,249 Cr. 4. Global Health also ranks among the premier healthcare institutions, holding a market capitalization of ₹28,786 Cr. 5. Narayana Hrudayalaya is recognized for its cost-effective cardiac care services and maintains a notable market share with a market capitalization of ₹26,086 Cr. In this report, we will conduct an in-depth analysis and comparison between two of India's leading healthcare providers, Apollo Hospitals and Narayana Hrudayalaya. This comprehensive evaluation will assess their technical and fundamental aspects, ◉ Company Overviews ● Apollo Hospital NSE:APOLLOHOSP Apollo Hospitals was founded in 1983 by Dr. Prathap C Reddy, a visionary in the evolution of modern healthcare in India. As the first corporate hospital in the country, Apollo Hospitals is celebrated for leading the charge in the private healthcare transformation. Today, Apollo Hospitals stands as Asia's leading integrated healthcare services provider, boasting a strong footprint throughout the healthcare landscape. This includes a diverse range of services such as hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. ● Narayana Hrudalaya NSE:NH Narayana Hrudayalaya Limited is involved in providing medical and healthcare services both in India and abroad. It functions through two main divisions: Medical and Healthcare Related Services, and Others. The organization is responsible for acquiring, owning, and managing a variety of healthcare facilities, including hospitals, clinics, health centres, diagnostic centres, and nursing homes, among other related operations. Its range of services encompasses cardiology, cardiac surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, pediatrics, neonatology, gastroenterology, and oncology. Additionally, the company is active in the health insurance sector. Established in 2000, its headquarters is located in Bengaluru, India. ◉ Technical Analysis ● Apollo Hospitals ➖ The stock faced a significant obstacle near the 5,800 level, resulted in a steep drop. ➖ It later found support around 3,500 and rebounded. ➖ Following an extended period of consolidation, the price developed a Rounding Bottom pattern. ➖ A breakout ensued, leading to a price increase, but it encountered resistance close to 6,800, which triggered a pullback to the breakout point. ➖ Following a successful retest, the price surged past the previous high, reaching a new peak at 7,545. ➖ However, due to prevailing negative market sentiments, the price has since retraced and is currently trading just above its immediate support zone. ● Narayana Hrudalaya ➖ The stock price is overall in an uptrend. ➖ After reaching an all-time high close to the 1,445 level, the price experienced a decline and has since entered a consolidation phase. ➖ A Symmetrical Triangle pattern has formed on the chart. ➖ We expect an upward breakout from this pattern, which could lead to a significant price rally. ◉ Relative Strength ➖ The chart reveals that both Apollo and Narayana Hrudayalaya have underperformed the Nifty Healthcare index. Although Apollo has given a descent 31% return, Narayana lagged significantly, yielding a modest 17% return. In contrast, the Nifty Healthcare index delivered an impressive 41% return. ◉ Service Wise Revenue Breakdown ● Apollo Hospitals The company operates through three primary segments, each contributing significantly to its revenue. ➖ Healthcare services account for approximately 52% of total revenue, forming the largest share. ➖ The retail pharmacy business generates nearly 41% of total sales, while the retail health and diagnostics segment contributes the remaining 7%. ● Narayana Hrudalaya ➖ The company operates exclusively in the healthcare services sector, deriving all its revenue from this single segment. ◉ Revenue & Profit Analysis ● Apollo Hospitals Year-over-Year ➖ The company's fiscal year 2024 performance was marked by strong growth, with revenue reaching ₹19,059 crore, a 15% increase from ₹16,612 crore in FY23. ➖ EBITDA surged to ₹2,394 crore, up from ₹2,065 crore in FY23, while the EBITDA margin improved to 13% from 12%. Quarter-over-Quarter ➖ In the latest quarter ending September 2024, the company achieved its highest-ever sales of ₹5,589 crore, significantly up from ₹5,086 crore in June 2024. This quarter-on-quarter growth has been consistent since March 2022. ➖ EBITDA for the quarter was an impressive ₹816 crore, a 21% increase from ₹675 crore in June 2024. ➖ Diluted EPS (LTM) rose substantially to ₹83.31 from ₹72.13 in June 2024. ● Narayana Hrudalaya Year-over-Year ➖ In FY24, our company achieved remarkable sales growth, surging 11% to ₹5,018 crore from ₹4,525 crore in FY23. ➖ EBITDA soared to ₹1,173 crore, up from ₹987 crore in the same period, with an impressive EBITDA margin of 23%. Quarter-over-Quarter ➖ Our quarterly sales reached an all-time high of ₹1,400 crore in September, representing a 4% increase from ₹1,341 crore in June. ➖ Although EBITDA growth was modest, it still improved to ₹308 crore in September from ₹304 crore in June 2024. ➖ However, Diluted EPS experienced a decline, dropping to ₹38.85 from ₹39.72. ◉ Valuation ● P/E Ratio ➖ Apollo Hospitals' current P/E ratio stands at 83.4, down from its 1-year median of 107.7. However, this remains significantly above the industry average of 56.9, indicating overvaluation. ➖ In contrast, Narayana Hrudalaya's P/E ratio of 33.5 is slightly above its 1-year median of 32.8 and substantially below the industry average, suggesting undervaluation. ● P/B Ratio ➖ Apollo's P/B ratio of 13.15 indicates considerable overvaluation compared to the industry average of 7.18. ➖ Narayana Hrudalaya's P/B ratio of 8.14 also suggests overvaluation, albeit to a lesser extent. ● PEG Ratio ➖ Narayana's PEG ratio of 0.49 positions it as an attractive investment opportunity, especially when compared to Apollo's considerably higher PEG of 2.43. ◉ Profitability Analysis ➖ Apollo Hospitals ROCE - 15% in FY24 ➖ Narayana Hrudalaya ROCE - 27% in FY24 The significant difference in ROCE between the two healthcare giants underscores Narayana Hrudalaya's superior profitability. Narayana's impressive ROCE of 27% demonstrates its ability to efficiently utilize its total capital, comprising both equity and debt, to generate substantially higher returns. ◉ Cash Flow Analysis ➖ Apollo Hospitals has demonstrated impressive growth in its operating cash flow, surging 39% to ₹1,920 crore in FY24 from ₹1,377 crore in FY23. This robust growth underscores the company's efficiency in converting profits into cash, highlighting its strong financial health and liquidity position. ➖ In contrast, Narayana Hrudalaya has shown sluggishness in turning profits into cash, with its operating cash flow declining 2% to ₹1,067 crore in FY24 from ₹1,085 crore in FY23. ◉ Debt Analysis ➖ Apollo Hospitals' debt stands at ₹7,371 crore, resulting in a debt-to-equity ratio of 0.98, which, although relatively high, is not alarming. However, the company's low interest coverage ratio of 4.69 raises concerns about its ability to service its debt. This vulnerability may complicate repayment of borrowed loans, potentially straining Apollo's financial stability. ➖ In contrast, Narayana Hrudalaya's debt of ₹1,703 crore and debt-to-equity ratio of 0.53 indicate robust financial health. Furthermore, its impressive interest coverage ratio of 8.34 suggests the company is well-positioned to manage its debt obligations, ensuring greater financial flexibility and stability. ◉ Shareholding Pattern ● Apollo Hospitals ➖ In the September quarter, Foreign Institutional Investors (FIIs) increased their stake in Apollo Hospitals to 45.37%, up from the previous quarter. ➖ Conversely, Domestic Institutional Investors (DIIs) reduced their holdings to 19.94%, a significant decrease from 24.77% in the last quarter. ● Narayana Hrudalaya ➖ In contrast, Narayana Hrudalaya witnessed a decline in institutional investor holdings. FIIs reduced their stake to 9.69%, down from 10% in the previous quarter. ➖ Domestic Institutional Investors (DIIs) also decreased their holdings to 7.9%, down from 8.22% in the June quarter. ◉ Conclusion Following a comprehensive analysis of both technical and fundamental aspects, we conclude that Narayana Hrudalaya appears to be favorably positioned from a valuation perspective, presenting an attractive investment opportunity. However, this does not diminish Apollo Hospitals' potential. Although the stock currently appears overvalued, investors can consider accumulating shares during dips, making it a viable option for those seeking strategic entry points. The healthcare sector's promising growth trajectory, fueled by rising healthcare demands and infrastructure expansion, positions both companies for potentially excellent returns in the near future.
NSE:APOLLOHOSPLong
by GoodluckCapital
2
Apollo Hospital and the EW CountsAPOLLOHOSP CMP 6989.. If we consider counts from May'22 lows, the 5 waves seems to have ended.. The minimum expected target of Wave 1 = wave 5 has already been met at 7220 levels.. Extended target is placed at 7800+.. Since the overall market is going down, this too looks poised to go down.. but Price action in the coming days will confirm the direction.. either case, a pullback/retracement is definitely on the cards to go below the recent swing low of 6727
NSE:APOLLOHOSPShort
by Murthy_Santhosh
APOLLOHOSP_Hormonic Reversal_Short sellingHarmonic 4-Point Pattern pattern has formed in the daily timeframe for apollo hospital and its reverse zone where between ( 7276 & 7391 ), we are expecting reversal start form this zones. RSI Day rsi had crossed 70+ which indicates the stock is in the overbought area. Conclusion It's nearly to harmonic reversal zone & Rsi also is over bought, so we are excepting 3-5℅ sell target, Plan accordingly to your trading plan setup coz nifty is getting HH formation trend is up side (All time High). Education Purpose only. Regards Sathish
NSE:APOLLOHOSPShort
by Satz_
3
APOLLO HOSP range analysis Certainly! Let’s take a look at the support and resistance levels for Apollo Hospitals Enterprises Ltd. (APOLLO HOSP): Support Levels: Short-Term Support: The stock has short-term support around ₹6,077.00. Long-Term Support: The 52-week low for APOLLOHOSP is ₹4,726.00. Resistance Levels: Short-Term Resistance: The stock faces short-term resistance around ₹6,163.75. Long-Term Resistance: The 52-week high for APOLLOHOSP is ₹6,874.45. Remember that these levels are based on historical price ranges and can change over time. Consider conducting your own analysis and due diligence before making investment decisions. 📈🔍
NSE:APOLLOHOSP
by vkfincare09
APOLLOHOSP breakout – is this the right time to go long?Sep 8, 2024 After the Covid-19 crash, Apollo Hospitals (APOLLOHOSP) has completed Degrees (Waves) 1 and 2, and is right now in Degree (Wave) 3. In Degree (Wave) 3, the stock has completed subwaves 3.1 and 3.2. Subwave 3.3 is near completion. Post completion of subwave 3.3, it would be time for corrective subwave 3.4 to begin, which should take the price down to 38.2% Fib level. We are expecting subwave 3.4 to retrace to only around 38.2% Fib level, because subwave 3.2 was a moderate correction, which retraced by only 50%. Also, subwave 3.4 should be a Zig-Zag correction, as subwave 3.2 was a regular flat. Post completion of subwave 3.4, we should see the beginning of the last phase of Degree (Wave) 3, which is 3.5. This would be the right time to go long. The expectation for Degree (Wave) 3.5 is to reach at least 100% Fib extension, which should take price of the stock to around Rs. 8,249. However, if subwave 3.5 goes into extension, it should reach 161.8% Fib extension, which will take the price of Apollohosp to around Rs. 11,270. Share the name of the stock you're interested in, and we'll be more than happy to conduct a thorough analysis for you. Disclaimer: We are not SEBI registered. The content presented here is based on personal opinions. Conduct your own research and consult with a qualified financial advisor before making any investment decisions.
NSE:APOLLOHOSP
by WaveMoku
APOLLOHOSP - CHART ANALYSIS Key Observations: Uptrend: The chart indicates a strong uptrend over the long term, showing significant growth in Apollo Hospitals' stock price. Price Patterns: Correction Phase: There was a notable correction where the price dropped by 39.05% (₹2,233.20). This correction might have served as a consolidation phase before the next upward move. Recovery and Growth: Following the correction, the stock recovered and surged by 40.94% (₹2,332.65), indicating a strong bullish momentum. Current Price: The latest price on the chart is ₹6,927.50, reflecting a healthy recovery and continuation of the uptrend. Volume: The CVD (Cumulative Volume Delta) indicator at the bottom shows the net volume flow, which has generally been positive, supporting the price increase. Conclusion:
NSE:APOLLOHOSPLong
by shivtoshiva2022
Apollo Hospitals Enterprises Ltd. @ 6688Sector: Hospital & Healthcare Services Strong Performer Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators Promoters pledge remained unchanged at 16.09% of holdings in Jun 2024 qtr. 52 Week High 6874.45 52 Week Low 4726 All Time High 6874.45 All Time Low 27 Book Value Per Share 482.35 Dividend Yield: 0.24 Sector PE 84.14 Face Value 5 Beta 0.56 Mkt Cap (Rs. Cr.) 96,191 RESISTANCE: 6875 SUPPORTS: 6617/6421/5689 UPSIDE CAN BE: 6839, 7205, 7707, 8150, 8377, 8738
NSE:APOLLOHOSP
by kacraj
Apollo Hospitals Enterprises Ltd. @ 6688Sector: Hospital & Healthcare Services Strong Performer Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators Promoters pledge remained unchanged at 16.09% of holdings in Jun 2024 qtr. 52 Week High 6874.45 52 Week Low 4726 All Time High 6874.45 All Time Low 27 Book Value Per Share 482.35 Dividend Yield: 0.24 Sector PE 84.14 Face Value 5 Beta 0.56 Mkt Cap (Rs. Cr.) 96,191 RESISTANCE: 6875 SUPPORTS: 6617/6421/5689 UPSIDE CAN BE: 6839, 7205, 7707, 8150, 8377, 8738
NSE:APOLLOHOSP
by kacraj